Heart disease remains the foremost cause of death globally responsible for approximately 17.9 million deaths annually This article examines the principal modifiable and non-modifiable risks factors of cardiovascular diseases (CVD) including hypertension, high cholesterol, diabetes mellitus, obesity, physical inactivity, tobacco use and excessive alcohol consumption and presents comprehensive evidence-based lifestyle strategies for its prevention and management. Cardiovascular diseases encompass coronary artery diseases (CAD), heart failure, arrhythmias and stroke. According to the Global Burden of Disease (GBD) 2023 study, CVDs are the leading cause of disability -adjusted life years (DALYs) and death globally, with an estimated 437 million CVD-related DALYs in 2023, a 1.4-fold increase since 1990. In the United States over 697,000 deaths were attributed to heart diseases in 2023 representing 25% of all deaths. CAD, the most common form, accounts for 40% of heart- related deaths annually, and someone in the US suffers a CAD-related heart attack every 40 seconds. Crucially, up to 82% of myocardial infarctions and 73% of strokes are preventable through healthy habits including appropriate diet, regular physical activity, healthy body weight management and not smoking.
CAUSES AND RISK FACTORS OF HEART DISEASES
Heart disease is multifactorial in origin arising from the interplay of non-modifiable risk factors, which are [Age (High risk at 45 years for Men and 55 for women), Sex, family history] and modifiable risk factors, which are the focus of preventive efforts (hypertension, diabetes mellitus, obesity, physical inactivity, tobacco use excessive, alcohol consumption and psychosocial stress).
HYPERTENSION (HIGH BLOOD PRESSURE):
Affecting over 1.28 billion people globally is the single most significant cardiovascular risk factor. Sustained elevated blood pressure imposes mechanical stress on arterial walls triggering endothelial dysfunction, arterial stiffness, left ventricular hypertrophy and ultimately heart failure. Because it typically produces no symptoms, hypertension is often called a ‘silent killer’. Both the 2024 European Society of Cardiology and the American Heart Association guidelines recommend maintaining blood pressure below 130/80mmHg, with stricter targets for high-risk groups such as those with diabetes or chronic kidney disease.
DYSLIPIDAEMIA (HIGH CHOLESTEROL):
Dyslipidaemia — characterised by elevated low-density lipoprotein (LDL) cholesterol, reduced high-density lipoprotein (HDL) cholesterol, or elevated triglycerides — is a central driver of atherosclerosis. Excess LDL cholesterol infiltrates arterial walls, undergoes oxidation, and triggers inflammatory responses that culminate in the formation of fibrous plaques, narrowing blood vessels and restricting blood flow to the heart. The American Heart Association (AHA) identifies high blood cholesterol as one of the three primary risk factors for heart disease, alongside hypertension and smoking. Epidemiological data indicate that approximately 47% of adults in the United States have at least one of these three major risk factors
DIABETES MELLITUS:
Diabetes mellitus substantially elevates the risk of cardiovascular disease through multiple pathological mechanisms. Chronic hyperglycaemia damages blood vessels and the autonomic nerves that regulate cardiac function, accelerating the progression of atherosclerosis and increasing susceptibility to CAD, heart failure, and peripheral artery disease. Meta-analytic evidence indicates that the pooled relative risk of incident coronary heart disease is approximately twofold higher in adults with type 2 diabetes compared to those without the condition, with women experiencing disproportionately higher relative risks. The ADA recommends that cardiovascular risk factors — including obesity, hypertension, dyslipidaemia, smoking, family history of premature coronary disease, and chronic kidney disease — be systematically assessed at least annually in all persons with diabetes.
OBESITY AND PHYSICAL INACTIVITY:
Obesity is a potent cardiovascular risk factor, capable of inducing or exacerbating hypertension, dyslipidaemia, and type 2 diabetes, conditions that independently and collectively increase heart disease risk. Adipose tissue, particularly visceral fat, releases pro-inflammatory cytokines and hormones that promote endothelial dysfunction and systemic inflammation, facilitating atherosclerotic plaque formation. Physical inactivity compounds this risk: sedentary behaviour is independently associated with higher cardiovascular mortality and morbidity, even after adjusting for other risk factors. Physical inactivity can also precipitate obesity, hypertension, elevated cholesterol, and diabetes, creating a self-reinforcing cycle of cardiovascular risk. Regular aerobic and resistance exercise has been shown to reduce each of these intermediary risk factors and to exert direct cardioprotective effects.
PREVENTION THROUGH HEALTHY LIFESTYLES
The evidence supporting lifestyle modification for primary prevention of heart disease is robust and conclusive. A comprehensive analysis estimated that maintaining five low-risk lifestyle habits could prevent as many as 82.2% of myocardial infarctions and 73.1% of strokes. These habits encompass a healthy diet, regular physical activity, maintenance of healthy body weight, not smoking, and moderate alcohol consumption. The following sections elaborate on each of these preventive strategies.
HEART-HEALTHY DIET
Diet is a cornerstone of CVD prevention. The AHA’s 2026 scientific statement identifies key features of cardioprotective diets: abundant vegetables, fruits, and whole grains; preference for plant-based and lean proteins; replacement of saturated fats with unsaturated fats; and minimization of added sugars, sodium, and ultra-processed foods. The Mediterranean diet is the most extensively validated pattern: a 2024 meta-analysis of 28 studies (n = 679,259 older adults) found that adherence reduced all-cause mortality by 23% and cardiovascular mortality by 27%. Ultra-processed food consumption, conversely, is independently linked to increased cardiovascular mortality. Include antioxidant-rich drinks like Turkey Berry Hibiscus Tea as part of a balanced diet. More heart-healthy drink ideas: www.achieverfoods.net
PHYSICAL ACTIVITY AND WEIGHT MANAGEMENT
Regular aerobic exercise reduces blood pressure, lowers LDL cholesterol, raises HDL cholesterol, enhances insulin sensitivity, and supports healthy body weight all through direct cardioprotective mechanisms. Current guidelines recommend at least 150 minutes of moderate-intensity aerobic activity per week supplemented by muscle-strengthening exercises on two or more days. A 2024 AHA statement further confirmed that resistance training yields significant improvements in cardiovascular risk factors in individuals both with and without CVD. Even modest weight loss of 5–10% of body weight produces clinically meaningful reductions in blood pressure, LDL cholesterol, and fasting glucose. Stay active and hydrated. See our wellness Tukey Berry Sim teas at: www.achieverfoods.net
STRESS REDUCTION AND MENTAL WELLBEING
Given the established link between psychosocial stress and adverse cardiovascular outcomes, stress management is increasingly incorporated into comprehensive heart disease prevention programmes. Effective stress-reduction strategies include mindfulness-based stress reduction (MBSR), cognitive-behavioural therapy (CBT), regular physical activity, social support networks, and adequate sleep. Improving sleep quality is particularly important, as studies show that poor sleep is independently associated with hypertension, obesity, and increased cardiovascular mortality. Mental health screening and management should therefore be integrated into routine cardiovascular risk assessment. Calming rituals like an evening cup of Turkey Berry Mint Tea can support stress management. Explore our blends: www.achieverfoods.net
SMOKING CESSATION, ALCOHOL MODERATION.
Smoking cessation reduces excess CAD risk by half within one year; after 15 years, risk approaches that of a non-smoker. Cessation benefits are observable even in long-term heavy smokers and at older ages. Evidence-based cessation strategies include behavioural counselling, nicotine replacement therapy (NRT), and pharmacological agents such as varenicline. Public health programmes promoting tobacco control and cessation support are therefore critical components of national CVD prevention strategies. Alcohol intake should be limited to no more than one drink per day for women and two for men.
MANAGEMENT OF HEART DISEASE THROUGH HEALTHY LIFESTYLES
For individuals already diagnosed with heart disease, lifestyle modification remains a foundational component of secondary prevention and disease management. The World Heart Federation’s 2023 Roadmap for Secondary Prevention of Cardiovascular Disease identifies smoking cessation, physical activity, diet and weight management, and cardiac rehabilitation as core elements of effective secondary prevention. Evidence consistently shows that these measures reduce the risk of recurrent events and mortality in patients with established CVD. Use trusted resources to build healthy habits
DIETARY MANAGEMENT IN ESTABLISHED HEART DISEASE
In patients with established cardiovascular disease, dietary interventions target multiple risk pathways simultaneously. Sodium restriction is recommended to manage blood pressure, while saturated fat and trans-fat reduction aims to lower LDL cholesterol and reduce atherosclerotic progression. Patients with heart failure benefit from fluid restriction and close dietary monitoring to prevent fluid overload. The Mediterranean and DASH (Dietary Approaches to Stop Hypertension) diets have demonstrated efficacy in secondary prevention, reducing rates of recurrent myocardial infarction and cardiovascular death. Work with your doctor on a heart- friendly meal plan, and include Daliha Turkey Berry Tea products. More support ideas: www.achieverfoods.net
EXERCISE IN CARDIAC PATIENTS:
Supervised exercise training in cardiac patients improves aerobic capacity, reduces sympathetic nervous system activation, lowers blood pressure, and improves endothelial function. Regular exercise also attenuates the neurohormonal and inflammatory mechanisms that drive heart failure progression. Current guidelines recommend that patients with stable CVD engage in at least 150 minutes of moderate-intensity aerobic exercise per week, with exercise intensity individualized based on clinical status and functional capacity. For patients at higher risk, exercise should be initiated under medical supervision within a formal cardiac rehabilitation setting.
SELF-MANAGEMENT, EDUCATION, AND DIGITAL HEALTH
Effective long-term management of heart disease requires active patient engagement in self-monitoring, adherence to treatment plans, and timely recognition of warning signs. Patient education covering disease mechanisms, medication adherence, dietary principles, and symptom recognition has been shown to improve clinical outcomes and quality of life in patients with heart failure and CAD. A narrative review synthesizing evidence from 2000 to 2025 found that structured patient education, exercise, and dietary modification consistently enhanced clinical outcomes, while digital health interventions offered promising but variable long-term benefits. Addressing socioeconomic disparities in access to education, healthcare, and healthy food environments is equally critical to achieving equitable cardiovascular outcomes. Use trusted resources to build healthy habits. Get healthy teas at: www.achieverfoods.net
CONCLUSION
Heart disease imposes an enormous and growing burden on global health, yet remains largely preventable and manageable through lifestyle modification. Hypertension, dyslipidaemia, diabetes, obesity, physical inactivity, tobacco use, excessive alcohol, and psychosocial stress are the principal modifiable risk factors, each addressable through accessible behavioural changes. A heart-healthy lifestyle encompassing a nutrient-rich diet, regular physical activity, healthy body weight, tobacco abstinence, moderate alcohol intake, adequate sleep, and effective stress management is the most powerful strategy available for reducing cardiovascular risk, capable of preventing more than 80% of cardiac events.
For those with established CVD, the same lifestyle strategies combined with pharmacological treatment and cardiac rehabilitation substantially reduce recurrent events and improve prognosis. Realizing this preventive potential requires sustained investment in public health education, equitable access to healthcare, supportive food and physical activity environments, and innovative digital health solutions. Prioritizing these strategies is the most sustainable pathway to reducing the global burden of cardiovascular disease.
References
American Diabetes Association (ADA). (2024) https://doi.org/10.2337/dc24-S010
American Heart Association (AHA). (2026) https://doi.org/10.1161/CIR.0000000000001435
Centers for Disease Control and Prevention (CDC). (2024a) https://www.cdc.gov/heart-disease/data-research/facts-stats/index.html
Centers for Disease Control and Prevention (CDC). (2024b) https://www.cdc.gov/heart-disease/risk-factors/index.html
CVRTI (Cardiovascular Research and Training Institute, University of Utah). (2024). https://cvrti.utah.edu/2024-heart-disease-statistics-and-their-implications/
GBD Collaborators. (2025). https://doi.org/10.1016/j.jacc.2025.08.015
Institute for Functional Medicine. (2024). Lifestyle interventions to modify cardiovascular disease risk. https://www.ifm.org/articles/lifestyle-interventions-modify-cardiovascular-disease
National Center for Biotechnology Information (NCBI). (2023) https://www.ncbi.nlm.nih.gov/books/NBK597416/
National Center for Biotechnology Information (NCBI). (2025) https://pmc.ncbi.nlm.nih.gov/articles/PMC12746952/
Petrie, J. R., et al. (2025) https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11856785/
https://powertechjournal.com/index.php/journal/article/download/2457/1753/4705
Tasnim, S., et al. (2024) https://pmc.ncbi.nlm.nih.gov/articles/PMC11433171/
Tsao, C. W., Aday, A. W., Almarzooq, Z. I., et al. (2023) https://doi.org/10.1161/CIR.0000000000001123
Volterrani, M., & Caminiti, G. (2023) https://doi.org/10.3389/fcvm.2023.1298422
World Heart Federation. (2024) https://doi.org/10.5334/gh.12